Welcome!

News Feed Item

Arterial Calcification Global Clinical Trials Review, H2, 2014

NEW YORK, Sept. 2, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Arterial Calcification Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02353405/Arterial-Calcification-Global-Clinical-Trials-Review-H2-2014.html

Arterial Calcification Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Arterial Calcification Global Clinical Trials Review, H2, 2014" provides data on the Arterial Calcification clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Arterial Calcification. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Arterial Calcification. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2

Introduction 5
Arterial Calcification 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Arterial Calcification to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Arterial Calcification to Cardiovascular Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Arterial Calcification Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Medestea Internazionale S.p.A. 27
Clinical Trial Overview of Medestea Internazionale S.p.A. 27
Amgen Inc. 28
Clinical Trial Overview of Amgen Inc. 28
Clinical Trial Overview of Top Institutes / Government 29
National Heart, Lung, and Blood Institute 29
Clinical Trial Overview of National Heart, Lung, and Blood Institute 29
Medical University of Lodz 30
Clinical Trial Overview of Medical University of Lodz 30
Romanian Society of Nephrology 31
Clinical Trial Overview of Romanian Society of Nephrology 31
Okayama University 32
Clinical Trial Overview of Okayama University 32
Kingston General Hospital 33
Clinical Trial Overview of Kingston General Hospital 33
Osaka University 34
Clinical Trial Overview of Osaka University 34
Aarhus University 35
Clinical Trial Overview of Aarhus University 35
Mayo Clinic in Rochester 36
Clinical Trial Overview of Mayo Clinic in Rochester 36
National Taiwan University Hospital 37
Clinical Trial Overview of National Taiwan University Hospital 37
University of Kentucky 38
Clinical Trial Overview of University of Kentucky 38
Five Key Clinical Profiles 39
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 68

List of Tables

Arterial Calcification Therapeutics, Global, Clinical Trials by Region, 2014* 6
Arterial Calcification Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Arterial Calcification Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Arterial Calcification Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Arterial Calcification Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Arterial Calcification Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Arterial Calcification Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Arterial Calcification Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Arterial Calcification Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Arterial Calcification Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Arterial Calcification Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Arterial Calcification Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Arterial Calcification Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Arterial Calcification Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Arterial Calcification Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Medestea Internazionale S.p.A., 2014* 27
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 28
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 29
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Lodz, 2014* 30
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Romanian Society of Nephrology, 2014* 31
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University, 2014* 32
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Kingston General Hospital, 2014* 33
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2014* 34
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014* 35
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic in Rochester, 2014* 36
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 37
Arterial Calcification Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2014* 38

List of Figures

Arterial Calcification Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Arterial Calcification Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Arterial Calcification Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Arterial Calcification Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Arterial Calcification Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Arterial Calcification Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Arterial Calcification to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Arterial Calcification Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Arterial Calcification Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Arterial Calcification Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Arterial Calcification Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Arterial Calcification Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Arterial Calcification Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Arterial Calcification Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Arterial Calcification Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Arterial Calcification Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Arterial Calcification Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 67

To order this report: Arterial Calcification Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02353405/Arterial-Calcification-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Widespread fragmentation is stalling the growth of the IIoT and making it difficult for partners to work together. The number of software platforms, apps, hardware and connectivity standards is creating paralysis among businesses that are afraid of being locked into a solution. EdgeX Foundry is unifying the community around a common IoT edge framework and an ecosystem of interoperable components.
In his session at 21st Cloud Expo, Raju Shreewastava, founder of Big Data Trunk, will provide a fun and simple way to introduce Machine Leaning to anyone and everyone. Together we will solve a machine learning problem and find an easy way to be able to do machine learning without even coding. Raju Shreewastava is the founder of Big Data Trunk (www.BigDataTrunk.com), a Big Data Training and consulting firm with offices in the United States. He previously led the data warehouse/business intellige...
Gemini is Yahoo’s native and search advertising platform. To ensure the quality of a complex distributed system that spans multiple products and components and across various desktop websites and mobile app and web experiences – both Yahoo owned and operated and third-party syndication (supply), with complex interaction with more than a billion users and numerous advertisers globally (demand) – it becomes imperative to automate a set of end-to-end tests 24x7 to detect bugs and regression. In th...
As popularity of the smart home is growing and continues to go mainstream, technological factors play a greater role. The IoT protocol houses the interoperability battery consumption, security, and configuration of a smart home device, and it can be difficult for companies to choose the right kind for their product. For both DIY and professionally installed smart homes, developers need to consider each of these elements for their product to be successful in the market and current smart homes.
Infoblox delivers Actionable Network Intelligence to enterprise, government, and service provider customers around the world. They are the industry leader in DNS, DHCP, and IP address management, the category known as DDI. We empower thousands of organizations to control and secure their networks from the core-enabling them to increase efficiency and visibility, improve customer service, and meet compliance requirements.
In his session at 21st Cloud Expo, Michael Burley, a Senior Business Development Executive in IT Services at NetApp, will describe how NetApp designed a three-year program of work to migrate 25PB of a major telco's enterprise data to a new STaaS platform, and then secured a long-term contract to manage and operate the platform. This significant program blended the best of NetApp’s solutions and services capabilities to enable this telco’s successful adoption of private cloud storage and launchi...
The session is centered around the tracing of systems on cloud using technologies like ebpf. The goal is to talk about what this technology is all about and what purpose it serves. In his session at 21st Cloud Expo, Shashank Jain, Development Architect at SAP, will touch upon concepts of observability in the cloud and also some of the challenges we have. Generally most cloud-based monitoring tools capture details at a very granular level. To troubleshoot problems this might not be good enough.
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In their Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, and Mark Lav...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
Smart cities have the potential to change our lives at so many levels for citizens: less pollution, reduced parking obstacles, better health, education and more energy savings. Real-time data streaming and the Internet of Things (IoT) possess the power to turn this vision into a reality. However, most organizations today are building their data infrastructure to focus solely on addressing immediate business needs vs. a platform capable of quickly adapting emerging technologies to address future ...
SYS-CON Events announced today that mruby Forum will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. mruby is the lightweight implementation of the Ruby language. We introduce mruby and the mruby IoT framework that enhances development productivity. For more information, visit http://forum.mruby.org/.
The dynamic nature of the cloud means that change is a constant when it comes to modern cloud-based infrastructure. Delivering modern applications to end users, therefore, is a constantly shifting challenge. Delivery automation helps IT Ops teams ensure that apps are providing an optimal end user experience over hybrid-cloud and multi-cloud environments, no matter what the current state of the infrastructure is. To employ a delivery automation strategy that reflects your business rules, making r...
Digital transformation is changing the face of business. The IDC predicts that enterprises will commit to a massive new scale of digital transformation, to stake out leadership positions in the "digital transformation economy." Accordingly, attendees at the upcoming Cloud Expo | @ThingsExpo at the Santa Clara Convention Center in Santa Clara, CA, Oct 31-Nov 2, will find fresh new content in a new track called Enterprise Cloud & Digital Transformation.
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software. They hope to capture value from emerging technologies such as IoT, SDN, and AI. Ultimately, irrespective of the vertical, it is about deriving value from independent software applications participating in an ecosystem as one comprehensive solution. In his session at @ThingsExpo, Kausik Sridhar, founder and CTO of Pulzze Systems, will discuss how given the magnitude of today's applicati...